DSpace Fukushima Medical University

福島県立医科大学学術成果リポジトリ = Fukushima Medical University Repository >
福島医学会 = The Fukushima Society of Medical Science >
Fukushima Journal of Medical Science >
Vol.69 (2023) >

このアイテムの引用には次の識別子を使用してください: http://ir.fmu.ac.jp/dspace/handle/123456789/2157

このアイテムのファイル:

ファイル 記述 サイズフォーマット
FksmJMedSci_69_p105.pdf779.14 kBAdobe PDFダウンロード
タイトル: Prediction of the prognosis of somatoform disorders using the Minnesota Multiphasic Personality Inventory
著者: Sato, Akiko
Itagaki, Shuntaro
Matsumoto, Takatomo
Ise, Yoko
Yokokura, Shunya
Wada, Tomohiro
Hayashi, Kaoru
Kakamu, Takeyasu
Fukushima, Tetsuhito
Nikaido, Takuya
Konno, Shinichi
Yabe, Hirooki
学内所属: 神経精神医学講座
衛生学・予防医学講座
整形外科学講座
誌名/書名: Fukushima Journal of Medical Science
巻: 69
号: 2
開始ページ: 105
終了ページ: 113
発行日: 2023年
抄録: Background: Somatoform disorders are frequently resistant to treatment. This study aimed to determine the utility of the Minnesota Multifaceted Personality Inventory (MMPI) in predicting the prognosis of somatoform disorders. Methods: Overall, 125 patients diagnosed with somatoform disorders between January 1, 2013 and December 31, 2017 in the psychiatric department of Fukushima Medical University Hospital were included. Patients with positive outcomes were identified based on a subjective estimation regarding (1) pain and (2) social functions, including activities of daily living. They were divided into the improved group (IG) and the non-improved group (NIG). Each factor was then descriptively compared between the two groups, and the sensitivity and specificity were determined. Results: The NIG had significantly higher scores but only on the Hy scale. Thus, the optimal Hy scale cutoff score was calculated. The cutoff point was 73.5, with a sensitivity of 55.7% and a specificity of 71.7%. Conclusion: An MMPI Hy scale score higher than a cutoff value of 73.5 predicts a poor response to conventional supportive psychotherapy or drug therapy in patients with somatoform disorders. This cutoff point may be used as an important index for selecting treatment for somatoform disorders.
出版者: The Fukushima Society of Medical Science
出版者(異表記): 福島医学会
本文の言語: eng
このページのURI: http://ir.fmu.ac.jp/dspace/handle/123456789/2157
本文URL: http://ir.fmu.ac.jp/dspace/bitstream/123456789/2157/1/FksmJMedSci_69_p105.pdf
ISSN: 0016-2590
2185-4610
DOI: 10.5387/fms.2022-04
PubMed番号: 37164766
関連ページ: https://doi.org/10.5387/fms.2022-04
権利情報: © 2023 The Fukushima Society of Medical Science. This article is licensed under a Creative Commons [Attribution-NonCommercial-ShareAlike 4.0 International] license.
権利情報: https://creativecommons.org/licenses/by-nc-sa/4.0/
出現コレクション:Vol.69 (2023)

このアイテムのファイル:

ファイル 記述 サイズフォーマット
FksmJMedSci_69_p105.pdf779.14 kBAdobe PDFダウンロード

このリポジトリに保管されているアイテムは、他に指定されている場合を除き、著作権により保護されています。

 

DSpace Software Copyright © 2002-2006 MIT and Hewlett-Packard